To investigate the expression of hepcidin in regulating ferroportin in prostrate cells, they tested expression in prostate cancer cells and non-malignant prostate epithelial cells and also examined cancer cells whose proliferation is either sensitive or insensitive to androgen. The gene discussed is HAMP; the disease is prostate carcinoma.